Vimarsana
Biggest News Aggregation in the World

Thomas Dalton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Dalton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Dalton Today - Breaking & Trending Today

WJLA ABC 7 News At Noon May 28, 2015 - Vimarsana News

WJLA ABC 7 News At Noon May 28, 2015

The details. Jeff Police Still Investigating a fatal road rage shooting. Still looking for the suspect in this case. Very much an active crime scene. You can see that the freeway is completely shut down. The metropolitan Police Department investigating the scene. This freeway remains an active crime scene. Heres the video of the suv involved. This is riddled with bullet holes. No word on how many shots fired. Between 845 and 855, some kind of a road rage altercation happened between vehicles on 295 north. Someone shot at this black suv bringing it to a stop. One man was killed, another man inj...

FDA Clears Cingulate to File for Marketing Approval of - Vimarsana News

FDA Clears Cingulate to File for Marketing Approval of

Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD - Vimarsana News

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD

Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application        CTx-1301 Could Benefit >60% of ADHD Patients Currently ...

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board ... - Vimarsana News

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board ...

KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access - Vimarsana News

Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access

KANSAS CITY, Kan., April 30, 2024 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a...